July 2025 Tender Notification I
Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2024/25 Invitation to Tender dated 31 October 2024.
Some of the Pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of Pharmaceuticals that are subject to such contracts should continue to supply their Pharmaceutical under those contracts. Pharmac will continue to subsidise those Pharmaceuticals accordingly until such time as those Pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:
- For new listings, by 4 pm on the 12th of August 2025 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4 pm on the 12th of the month prior to the date of subsidy change
Pharmac cannot list a product (and Pharmacies cannot claim) without this information. More information about this process, and a copy of the NOPC form can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). Pharmac cannot list a product (and Pharmacies cannot claim) without the correct Pharmacode.
- 30 July 2025 Tender Notification I [PDF 391 KB]
2024/25 Tender – Principal Supply Status applies until 30 June 2028
Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule
The decisions were as follows:
1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
Date of subsidy change |
Principal Supply date |
---|---|---|---|---|---|---|
Abacavir sulphate with lamivudine |
Tab 600 mg with lamivudine 300 mg; 30 tablet blister pack |
$29.50 |
$35.00 |
Abacavir/Lamivudine Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Aciclovir |
Tab dispersible 200 mg; 25 tablet blister pack |
$1.78 |
$2.05 |
Lovir (Douglas) |
1 September 2025 |
1 February 2026 |
Aciclovir |
Tab dispersible 400 mg; 56 tablet blister pack |
$5.81 |
$7.55 |
Lovir (Douglas) |
1 September 2025 |
1 February 2026 |
Aciclovir |
Tab dispersible 800 mg; 35 tablet blister pack |
$6.46 |
$7.43 |
Lovir (Douglas) |
1 September 2025 |
1 February 2026 |
Amiodarone hydrochloride |
Inj 50 mg per ml, 3 ml ampoule, 10 ampoule pack |
$15.22 |
$17.96 |
Max Health (Max Health) |
1 September 2025 |
1 February 2026 |
Amiodarone hydrochloride |
Tab 100 mg; 30 tablet blister pack |
$3.49 |
$4.95 |
Aratac (Viatris) |
1 September 2025 |
1 February 2026 |
Amiodarone hydrochloride |
Tab 200 mg; 30 tablet blister pack |
$4.49 |
$5.86 |
Aratac (Viatris) |
1 September 2025 |
1 February 2026 |
Amoxicillin |
Cap 250 mg; 500 capsule bottle pack |
$27.50 |
$54.00 |
Miro-Amoxicillin (Miro) |
1 September 2025 |
1 February 2026 |
Ascorbic acid |
Tab 100 mg; 500 tablet bottle pack |
$12.50 |
$16.00 |
Cvite (Evara) |
1 October 2025 |
1 March 2026 |
Atazanavir sulphate |
Cap 150 mg; 60 capsule bottle pack |
$85.00 |
$102.50 |
Atazanavir Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Atazanavir sulphate |
Cap 200 mg; 60 capsule bottle pack |
$110.00 |
$152.30 |
Atazanavir Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Azathioprine |
Tab 25 mg; 60 tablet blister pack |
$7.36 |
$10.15 |
Azamun (Douglas) |
1 September 2025 |
1 February 2026 |
Azathioprine |
Tab 50 mg; 100 tablet blister pack |
$8.10 |
$10.34 |
Azamun (Douglas) |
1 September 2025 |
1 February 2026 |
Buprenorphine with Naloxone |
Tab sublingual 2 mg with naloxone 0.5 mg; 28 tablet blister pack |
$11.76 |
$11.76 |
Buprenorphine Naloxone BNM (Boucher) |
1 December 2025 |
1 May 2026 |
Buprenorphine with Naloxone |
Tab sublingual 8 mg with naloxone 2 mg; 28 tablet blister pack |
$34.00 |
$26.86 |
Buprenorphine Naloxone BNM (Boucher) |
1 December 2025 |
1 May 2026 |
Capecitabine |
Tab 150 mg; 60 tablet blister pack |
$9.80 |
$10.92 |
Capecitabine Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Capecitabine |
Tab 500 mg; 120 tablet blister pack |
$46.50 |
$50.96 |
Capecitabine Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Cefaclor monohydrate |
Cap 250 mg; 100 capsule bottle pack |
$25.85 |
$29.73 |
Ranbaxy-Cefaclor (Douglas) |
1 September 2025 |
1 February 2026 |
Cefaclor monohydrate |
Grans for oral liq 125 mg per 5 ml; 100 ml bottle |
$3.75 |
$5.83 |
Ranbaxy-Cefaclor (Douglas) |
1 September 2025 |
1 February 2026 |
Ceftriaxone |
Inj 500 mg vial; 1 vial pack |
$0.79 |
$0.94 |
Ceftriaxone-AFT (AFT) |
1 September 2025 |
1 February 2026 |
Ceftriaxone |
Inj 1 g vial; 5 vial pack |
$3.59 |
$3.49 |
Ceftriaxone-AFT (AFT) |
1 September 2025 |
1 February 2026 |
Chloramphenicol |
Eye oint 1%; 5 g tube |
$1.09 |
$1.55 |
Devatis (Devatis) |
1 September 2025 |
1 February 2026 |
Chlortalidone [Chlorthalidone] |
Tab 25 mg; 50 tablet bottle pack |
$6.95 |
$6.95 |
Hygroton (AFT) |
1 September 2025 |
1 February 2026 |
Clobetasol propionate |
Crm 0.05%; 30 g tube |
$2.40 |
$3.75 |
Dermol (Viatris) |
1 September 2025 |
1 February 2026 |
Clobetasol propionate |
Oint 0.05%; 30 g tube |
$2.33 |
$3.68 |
Dermol (Viatris) |
1 September 2025 |
1 February 2026 |
Clobetasol propionate |
Scalp app 0.05%; 30 ml bottle |
$6.26 |
$6.90 |
Dermol (Viatris) |
1 September 2025 |
1 February 2026 |
Clonidine hydrochloride |
Tab 25 mcg; 112 tablet blister pack |
$29.32 |
$29.74 |
Clonidine Teva (Teva) |
1 September 2025 |
1 February 2026 |
Clotrimazole |
Crm 1%; 20 g tube |
$1.10 |
$1.15 |
Clomazol (Multichem) |
1 February 2026 |
1 July 2026 |
Clotrimazole |
Vaginal crm 1% with applicators; 35 g tube |
$3.50 |
$4.20 |
Clomazol (Multichem) |
1 February 2026 |
1 July 2026 |
Clotrimazole |
Vaginal crm 2% with applicators; 20 g tube |
$3.85 |
$4.60 |
Clomazol (Multichem) |
1 February 2026 |
1 July 2026 |
Digoxin |
Tab 62.5 mcg; 240 tablet blister pack |
$7.80 |
$8.58 |
Lanoxin PG (Aspen) |
1 September 2025 |
1 February 2026 |
Digoxin |
Tab 250 mcg; 240 tablet blister pack |
$16.90 |
$18.75 |
Lanoxin (Aspen) |
1 September 2025 |
1 February 2026 |
Dihydrocodeine tartrate |
Tab long-acting 60 mg; 60 tablet bottle pack |
$8.60 |
$9.20 |
DHC Continus (Pharmaco) |
1 September 2025 |
1 February 2026 |
Fluoxetine hydrochloride |
Tab dispersible 20 mg, scored; 28 tablet blister pack |
$2.50 |
$2.37 |
Fluox (Viatris) |
1 October 2025 |
1 March 2026 |
Fluticasone propionate |
Metered aqueous nasal spray, 50 mcg per dose; 120 infusion pump bottle |
$2.57 |
$2.57 |
Flixonase Hayfever & Allergy (Haleon) |
1 March 2026 |
1 August 2026 |
Glycerol |
Suppos 2.8/4.0 g; 20 suppository foil pack |
$10.39 |
$12.39 |
Lax-suppositories Glycerol (AFT) |
1 September 2025 |
1 February 2026 |
Hydrocortisone1 |
Crm 1%; 30 g tube |
$1.78 |
$1.75 |
Ethics (Multichem) |
1 February 2026 |
1 July 2026 |
Lactulose |
Oral liq 10 g per 15 ml; 500 ml bottle |
$3.61 |
$6.16 |
Laevolac (Douglas) |
1 September 2025 |
1 February 2026 |
Lidocaine [Lignocaine] |
Gel 2%, 11 ml urethral syringe; 10 prefilled syringe pack |
$59.50 |
$65.45 |
Instillagel Lido (Inter) |
1 September 2025 |
1 February 2026 |
Lisinopril |
Tab 10 mg; 90 tablet blister pack |
$11.67 |
$12.00 |
Teva Lisinopril (Teva) |
1 October 2025 |
1 March 2026 |
Lisinopril |
Tab 20 mg; 90 tablet blister pack |
$14.69 |
$16.00 |
Teva Lisinopril (Teva) |
1 October 2025 |
1 March 2026 |
Lisinopril |
Tab 5 mg; 90 tablet blister pack |
$11.07 |
$12.00 |
Teva Lisinopril (Teva) |
1 October 2025 |
1 March 2026 |
Loperamide hydrochloride |
Cap 2 mg; 400 capsule blister pack |
$7.25 |
$12.00 |
Diamide Relief (Viatris) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Inj 5 mg per ml, 1 ml ampoule; 5 glass ampoule box |
$5.38 |
$5.96 |
Medsurge (Medsurge) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Inj 10 mg per ml, 1 ml ampoule; 5 glass ampoule box |
$4.68 |
$4.99 |
Medsurge (Medsurge) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Inj 15 mg per ml, 1 ml ampoule; 5 glass ampoule box |
$5.53 |
$6.93 |
Medsurge (Medsurge) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Inj 30 mg per ml, 1 ml ampoule; 5 glass ampoule box |
$6.28 |
$7.28 |
Medsurge (Medsurge) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Cap long-acting 10 mg; 10 capsule blister pack |
$3.00 |
$4.10 |
m-Eslon (Multichem) |
1 February 2026 |
1 July 2026 |
Morphine sulphate |
Cap long-acting 30 mg; 10 capsule blister pack |
$4.30 |
$6.05 |
m-Eslon (Multichem) |
1 February 2026 |
1 July 2026 |
Morphine sulphate |
Cap long-acting 60 mg; 10 capsule blister pack |
$9.00 |
$12.10 |
m-Eslon (Multichem) |
1 February 2026 |
1 July 2026 |
Morphine sulphate |
Cap long-acting 100 mg; 10 capsule blister pack |
$10.50 |
$14.50 |
m-Eslon (Multichem) |
1 February 2026 |
1 July 2026 |
Nicorandil |
Tab 10 mg; 60 tablet blister pack |
$21.73 |
$27.81 |
Max Health (Max Health) |
1 September 2025 |
1 February 2026 |
Nicorandil |
Tab 20 mg; 60 tablet blister pack |
$27.44 |
$35.12 |
Max Health (Max Health) |
1 September 2025 |
1 February 2026 |
Olopatadine |
Eye drops 0.1%; 5 ml dropper bottle |
$2.17 |
$3.39 |
Olopatadine Teva (Teva) |
1 October 2025 |
1 March 2026 |
Oxytocin |
Inj 10 iu per ml, 1 ml ampoule |
$5.98 |
$7.18 |
Oxytocin BNM (Boucher) |
1 October 2025 |
1 March 2026 |
Oxytocin |
Inj 5 iu per ml, 1 ml ampoule |
$4.98 |
$5.98 |
Oxytocin BNM (Boucher) |
1 October 2025 |
1 March 2026 |
Oxytocin with ergometrine maleate |
Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml ampoule; 5 glass ampoule carton |
$32.40 |
$41.47 |
Syntometrine (Max Health) |
1 September 2025 |
1 February 2026 |
Paracetamol with codeine |
Tab paracetamol 500 mg with codeine phosphate 8 mg; 1000 tablet blister pack |
$27.50 |
$31.95 |
Paracetamol + Codeine (Relieve) (Viatris) |
1 September 2025 |
1 February 2026 |
Paroxetine |
Tab 20 mg; 90 tablet blister pack |
$4.11 |
$4.98 |
Loxamine (Viatris) |
1 September 2025 |
1 February 2026 |
Pegfilgrastim |
Inj 6 mg per 0.6 ml syringe; 1 prefilled syringe injection |
$65.00 |
$69.50 |
Ziextenzo (Sandoz) |
1 September 2025 |
1 February 2026 |
Potassium chloride |
Tab long-acting 600 mg (8 mmol); 200 tablet bottle pack |
$15.35 |
$16.15 |
Span-K (Aspen) |
1 September 2025 |
1 February 2026 |
Risedronate sodium |
Tab 35 mg; 4 tablet blister pack |
$2.50 |
$3.00 |
Risedronate Sandoz (Sandoz) |
1 September 2025 |
1 February 2026 |
Sodium chloride |
Inj 0.9%, 5 ml ampoule; 20 plastic ampoule pack |
$4.00 |
$4.12 |
Fresenius Kabi (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Sodium chloride |
Inj 0.9%, 10 ml ampoule; 50 plastic ampoule pack |
$5.25 |
$7.50 |
Fresenius Kabi (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Sodium chloride |
Inj 0.9%, 20 ml ampoule; 20 plastic ampoule pack |
$5.00 |
$5.20 |
Fresenius Kabi (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Sodium citrate with sodium lauryl sulphoacetate |
Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml; 50 Enema tube |
$35.89 |
$36.89 |
Micolette (AFT) |
1 September 2025 |
1 February 2026 |
Sodium cromoglicate |
Eye drops 2%; 10 ml dropper bottle |
$2.62 |
$2.91 |
Allerfix (Teva) |
1 October 2025 |
1 March 2026 |
Sotalol |
Tab 80 mg; 500 tablet bottle pack |
$37.50 |
$40.00 |
Mylan (Viatris) |
1 September 2025 |
1 February 2026 |
Sotalol |
Tab 160 mg; 100 tablet bottle pack |
$14.00 |
$20.00 |
Mylan (Viatris) |
1 September 2025 |
1 February 2026 |
Tamsulosin hydrochloride |
Cap 400 mcg; 100 capsule blister pack |
$22.31 |
$28.56 |
Tamsulosin-Rex (Rex Medical) |
1 September 2025 |
1 February 2026 |
Tenoxicam |
Tab 20 mg; 100 tablet blister pack |
$18.50 |
$23.50 |
Tilcotil (Viatris) |
1 September 2025 |
1 February 2026 |
Tetrabenazine |
Tab 25 mg; 112 tablet bottle pack |
$106.59 |
$126.02 |
Motetis (Douglas) |
1 September 2025 |
1 February 2026 |
Vinorelbine |
Cap 20 mg; 1 capsule blister pack |
$30.00 |
$32.10 |
Vinorelbine Te Arai (TeArai) |
1 September 2025 |
1 February 2026 |
Vinorelbine |
Cap 30 mg; 1 capsule blister pack |
$40.00 |
$42.80 |
Vinorelbine Te Arai (TeArai) |
1 September 2025 |
1 February 2026 |
Vinorelbine |
Cap 80 mg; 1 capsule blister pack |
$60.00 |
$80.00 |
Vinorelbine Te Arai (TeArai) |
1 September 2025 |
1 February 2026 |
Zoledronic acid |
Inj 0.05 mg per ml, 100 ml, bag; 1 bag |
$22.53 |
$19.45 |
Zoledronic Acid Viatris |
1 September 2025 |
1 February 2026 |
1This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 4 clause 2.3(c)(ii) of the 2024/25 Invitation to Tender. |
2. Tenders awarded to currently listed pharmaceuticals where at least one other brand is listed.
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
Date of subsidy change |
Principal Supply date |
Brand (Supplier) affected by delisting |
---|---|---|---|---|---|---|---|
Celecoxib |
Cap 100 mg; 60 capsule blister pack |
$3.45 Celebrex (Aspen) |
$3.60 |
Celebrex (Aspen) |
1 September 2025 |
1 February 2026 |
Celecoxib Pfizer (Aspen) |
$3.45 Celecoxib Pfizer (Aspen) |
|||||||
Tranexamic acid |
Tab 500 mg; 60 tablet blister pack |
$45.68 (per 100) Cyklokapron (Pfizer) |
$9.93 (per 60) |
Mercury Pharma (Boucher) |
1 December 2025 |
1 May 2026 |
Cyklokapron (Pfizer) |
$10.45 (per 60) Mercury Pharma (Boucher) |
Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.
3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
Date of subsidy change |
Principal Supply date |
---|---|---|---|---|---|---|
Abacavir sulphate with lamivudine |
Tab 600 mg with lamivudine 300 mg, 30 tablet blister pack |
$29.50 |
$35.00 |
Abacavir/Lamivudine Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Aciclovir |
Tab dispersible 200 mg, 25 tablet blister pack |
$1.78 |
$2.05 |
Lovir (Douglas) |
1 September 2025 |
1 February 2026 |
Aciclovir |
Tab dispersible 400 mg, 56 tablet blister pack |
$5.81 |
$7.55 |
Lovir (Douglas) |
1 September 2025 |
1 February 2026 |
Aciclovir |
Tab dispersible 800 mg, 35 tablet blister pack |
$6.46 |
$7.43 |
Lovir (Douglas) |
1 September 2025 |
1 February 2026 |
Amiodarone hydrochloride |
Inj 50 mg per ml, 3 ml ampoule, 10 ampoule pack |
$15.22 |
$17.96 |
Max Health (Max Health) |
1 September 2025 |
1 February 2026 |
Amiodarone hydrochloride |
Tab 100 mg, 30 tablet blister pack |
$3.49 |
$4.95 |
Aratac (Viatris) |
1 September 2025 |
1 February 2026 |
Amiodarone hydrochloride |
Tab 200 mg, 30 tablet blister pack |
$4.49 |
$5.86 |
Aratac (Viatris) |
1 September 2025 |
1 February 2026 |
Amoxicillin |
Cap 250 mg; 500 capsule bottle pack |
$27.50 |
$54.00 |
Miro-Amoxicillin (Miro) |
1 September 2025 |
1 February 2026 |
Ascorbic acid |
Tab 100 mg; 500 tablet bottle pack |
$12.50 |
$16.00 |
Cvite (Evara) |
1 October 2025 |
1 March 2026 |
Atazanavir sulphate |
Cap 150 mg; 60 capsule bottle pack |
$85.00 |
$102.50 |
Atazanavir Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Atazanavir sulphate |
Cap 200 mg; 60 capsule bottle pack |
$110.00 |
$152.30 |
Atazanavir Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Azathioprine |
Tab 25 mg; 60 tablet blister pack |
$7.36 |
$10.15 |
Azamun (Douglas) |
1 September 2025 |
1 February 2026 |
Azathioprine |
Tab 50 mg; 100 tablet blister pack |
$8.10 |
$10.34 |
Azamun (Douglas) |
1 September 2025 |
1 February 2026 |
Bupivacaine hydrochloride with fentanyl |
Inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml bag; 5 bag pack |
$122.50 |
$135.00 |
Bupafen (Biomed) |
1 September 2025 |
1 February 2026 |
Bupivacaine hydrochloride with fentanyl |
Inj 1.25 mg with fentanyl 2 mcg per ml, 200 ml bag; 5 bag pack |
$127.50 |
$138.00 |
Bupafen (Biomed) |
1 September 2025 |
1 February 2026 |
Buprenorphine with naloxone |
Tab 2 mg with naloxone 0.5 mg; 28 tablet blister pack |
$11.76 |
$11.76 |
Buprenorphine Naloxone BNM (Boucher) |
1 December 2025 |
1 May 2026 |
Buprenorphine with naloxone |
Tab 8 mg with naloxone 2 mg; 28 tablet blister pack |
$34.00 |
$26.86 |
Buprenorphine Naloxone BNM (Boucher) |
1 December 2025 |
1 May 2026 |
Capecitabine |
Tab 150 mg; 60 tablet blister pack |
$9.80 |
$10.92 |
Capecitabine Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Capecitabine |
Tab 500 mg; 120 tablet blister pack |
$46.50 |
$50.96 |
Capecitabine Viatris (Viatris) |
1 September 2025 |
1 February 2026 |
Caspofungin |
Inj 50 mg vial; 1 vial injection |
$110.00 |
$110.00 |
Alchemy Caspofungin (Alchemy) |
1 October 2025 |
1 March 2026 |
Caspofungin |
Inj 70 mg vial; 1 vial injection |
$135.00 |
$135.00 |
Alchemy Caspofungin (Alchemy) |
1 October 2025 |
1 March 2026 |
Cefaclor monohydrate |
Cap 250 mg; 100 capsule bottle pack |
$25.85 |
$29.73 |
Ranbaxy-Cefaclor (Douglas) |
1 September 2025 |
1 February 2026 |
Cefaclor monohydrate |
Grans for oral liq 125 mg per 5 ml; 100 ml bottle |
$3.75 |
$5.83 |
Ranbaxy-Cefaclor (Douglas) |
1 September 2025 |
1 February 2026 |
Ceftriaxone |
Inj 500 mg vial; 1 vial pack |
$0.79 |
$0.94 |
Ceftriaxone-AFT (AFT) |
1 September 2025 |
1 February 2026 |
Ceftriaxone |
Inj 1 g vial; 5 vial pack |
$3.59 |
$3.49 |
Ceftriaxone-AFT (AFT) |
1 September 2025 |
1 February 2026 |
Ceftriaxone |
Inj 2 g vial; 5 vial pack |
$7.85 |
$8.15 |
Ceftriaxone-AFT (AFT) |
1 September 2025 |
1 February 2026 |
Chloramphenicol |
Eye oint 1%; 5 g tube |
$1.09 |
$1.55 |
Devatis (Devatis) |
1 September 2025 |
1 February 2026 |
Chlortalidone [Chlorthalidone] |
Tab 25 mg; 50 tablet bottle pack |
$6.95 |
$6.95 |
Hygroton (AFT) |
1 September 2025 |
1 February 2026 |
Clobetasol propionate |
Crm 0.05%; 30 g tube |
$2.40 |
$3.75 |
Dermol (Viatris) |
1 September 2025 |
1 February 2026 |
Clobetasol propionate |
Oint 0.05%; 30 g tube |
$2.33 |
$3.68 |
Dermol (Viatris) |
1 September 2025 |
1 February 2026 |
Clobetasol propionate |
Scalp app 0.05%; 30 ml bottle |
$6.26 |
$6.90 |
Dermol (Viatris) |
1 September 2025 |
1 February 2026 |
Clonidine hydrochloride |
Tab 25 mcg; 112 tablet blister pack |
$29.32 |
$29.74 |
Clonidine (Teva) |
1 September 2025 |
1 February 2026 |
Clotrimazole |
Crm 1%; 20 g tube |
$1.10 |
$1.15 |
Clomazol (Multichem) |
1 February 2026 |
1 July 2026 |
Clotrimazole |
Vaginal crm 1% with applicators; 35 g tube |
$3.50 |
$4.20 |
Clomazol (Multichem) |
1 February 2026 |
1 July 2026 |
Clotrimazole |
Vaginal crm 2% with applicators; 20 g tube |
$3.85 |
$4.60 |
Clomazol (Multichem) |
1 February 2026 |
1 July 2026 |
Digoxin |
Tab 62.5 mcg; 240 tablet blister pack |
$7.80 |
$8.58 |
Lanoxin PG (Aspen) |
1 September 2025 |
1 February 2026 |
Digoxin |
Tab 250 mcg; 240 tablet blister pack |
$16.90 |
$18.75 |
Lanoxin (Aspen) |
1 September 2025 |
1 February 2026 |
Dihydrocodeine tartrate |
Tab long-acting 60 mg; 60 tablet bottle pack |
$8.60 |
$9.20 |
DHC Continus (Pharmaco) |
1 September 2025 |
1 February 2026 |
Fluoxetine hydrochloride |
Tab dispersible 20 mg, scored; 28 tablet blister pack |
$2.50 |
$2.37 |
Fluox (Viatris) |
1 October 2025 |
1 March 2026 |
Fluticasone propionate |
Metered aqueous nasal spray, 50 mcg per dose; 120 infusion pump bottle |
$2.57 |
$2.57 |
Flixonase Hayfever & Allergy (Haleon) |
1 March 2026 |
1 August 2026 |
Glycerol |
Suppos 2.8/4.0 g; 20 suppository foil pack |
$10.39 |
$12.39 |
Lax-suppositories Glycerol (AFT) |
1 September 2025 |
1 February 2026 |
Hydrocortisone1 |
Crm 1%; 30 g tube |
$1.78 |
$1.75 |
Ethics (Multichem) |
1 February 2026 |
1 July 2026 |
Lactulose |
Oral liq 10 g per 15 ml; 500 ml bottle |
$3.61 |
$6.16 |
Laevolac (Douglas) |
1 September 2025 |
1 February 2026 |
Lidocaine [Lignocaine] |
Gel 2%, 11 ml urethral syringe; 10 prefilled syringe pack |
$59.50 |
$65.45 |
Instillagel Lido (Inter) |
1 September 2025 |
1 February 2026 |
Lidocaine [Lignocaine] hydrochloride |
Spray 10%; 50 ml pump bottle |
$78.95 |
$82.90 |
Xylocaine (Aspen) |
1 September2025 |
1 February 2026 |
Lisinopril |
Tab 10 mg; 90 tablet blister pack |
$11.67 |
$12.00 |
Teva Lisinopril (Teva) |
1 October 2025 |
1 March 2026 |
Lisinopril |
Tab 20 mg; 90 tablet blister pack |
$14.69 |
$16.00 |
Teva Lisinopril (Teva) |
1 October 2025 |
1 March 2026 |
Lisinopril |
Tab 5 mg; 90 tablet blister pack |
$11.07 |
$12.00 |
Teva Lisinopril (Teva) |
1 October 2025 |
1 March 2026 |
Loperamide hydrochloride |
Cap 2 mg; 400 capsule blister pack |
$7.25 |
$12.00 |
Diamide Relief (Viatris) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Inj 5 mg per ml, 1 ml ampoule; 5 glass ampoule box |
$5.38 |
$5.96 |
Medsurge (Medsurge) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Inj 10 mg per ml, 1 ml ampoule; 5 glass ampoule box |
$4.68 |
$4.99 |
Medsurge (Medsurge) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Inj 15 mg per ml, 1 ml ampoule; 5 glass ampoule box |
$5.53 |
$6.93 |
Medsurge (Medsurge) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Inj 30 mg per ml, 1 ml ampoule; 5 glass ampoule box |
$6.28 |
$7.28 |
Medsurge (Medsurge) |
1 September 2025 |
1 February 2026 |
Morphine sulphate |
Cap long-acting 10 mg; 10 capsule blister pack |
$3.00 |
$4.10 |
m-Eslon (Multichem) |
1 February 2026 |
1 July 2026 |
Morphine sulphate |
Cap long-acting 30 mg; 10 capsule blister pack |
$4.30 |
$6.05 |
m-Eslon (Multichem) |
1 February 2026 |
1 July 2026 |
Morphine sulphate |
Cap long-acting 60 mg; 10 capsule blister pack |
$9.00 |
$12.10 |
m-Eslon (Multichem) |
1 February 2026 |
1 July 2026 |
Morphine sulphate |
Cap long-acting 100 mg; 10 capsule blister pack |
$10.50 |
$14.50 |
m-Eslon (Multichem) |
1 February 2026 |
1 July 2026 |
Neostigmine metilsulfate with glycopyrronium bromide |
Inj 2.5 mg with glycopyrronium bromide 0.5 mg per ml, 1 ml ampoule; 10 glass ampoule pack |
$26.13 |
$26.13 |
Max Health (Max Health) |
1 September 2025 |
1 February 2026 |
Nicorandil |
Tab 10 mg; 60 tablet blister pack |
$21.73 |
$27.81 |
Max Health (Max Health) |
1 September 2025 |
1 February 2026 |
Nicorandil |
Tab 20 mg; 60 tablet blister pack |
$27.44 |
$35.12 |
Max Health (Max Health) |
1 September 2025 |
1 February 2026 |
Olopatadine |
Eye drops 0.1%; 5 ml dropper bottle |
$2.17 |
$3.39 |
Olopatadine Teva (Teva) |
1 October 2025 |
1 March 2026 |
Ondansetron hydrochloride |
Inj 2 mg per ml, 2 ml ampoule; 5 glass ampoule pack |
$1.42 |
$1.54 |
Ondansetron-AFT (AFT) |
1 September 2025 |
1 February 2026 |
Ondansetron hydrochloride |
Inj 2 mg per ml, 4 ml ampoule; 5 glass ampoule pack |
$1.89 |
$2.14 |
Ondansetron-AFT (AFT) |
1 September 2025 |
1 February 2026 |
Oxytocin |
Inj 10 iu per ml, 1 ml ampoule |
$5.98 |
$7.18 |
Oxytocin BNM (Boucher) |
1 October 2025 |
1 March 2026 |
Oxytocin |
Inj 5 iu per ml, 1 ml ampoule |
$4.98 |
$5.98 |
Oxytocin BNM (Boucher) |
1 October 2025 |
1 March 2026 |
Oxytocin with ergometrine maleate |
Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml ampoule; 5 glass ampoule carton |
$32.40 |
$41.47 |
Syntometrine (Max Health) |
1 September 2025 |
1 February 2026 |
Paracetamol |
Inj 10 mg per ml, 100 ml vial; 10 vial pack |
$15.00 |
$15.30 |
Paracetamol Kabi (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Paracetamol with codeine |
Tab paracetamol 500 mg with codeine phosphate 8 mg; 1000 tablet blister pack |
$27.50 |
$31.95 |
Paracetamol + Codeine (Relieve) (Viatris) |
1 September 2025 |
1 February 2026 |
Paroxetine |
Tab 20 mg; 90 tablet blister pack |
$4.11 |
$4.98 |
Loxamine (Viatris) |
1 September 2025 |
1 February 2026 |
Pegfilgrastim |
Inj 6 mg per 0.6 ml syringe; 1 prefilled syringe injection |
$65.00 |
$69.50 |
Ziextenzo (Sandoz) |
1 September 2025 |
1 February 2026 |
Potassium chloride |
Tab long-acting 600 mg (8 mmol); 200 tablet bottle pack |
$15.35 |
$16.15 |
Span-K (Aspen) |
1 September 2025 |
1 February 2026 |
Propofol |
Inj 10 mg per ml, 20 ml ampoule; 5 glass ampoule pack |
$4.35 |
$5.75 |
Fresofol 1% MCT/LCT (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Propofol |
Inj 10 mg per ml, 50 ml vial; 10 vial pack |
$19.50 |
$27.50 |
Fresofol 1% MCT/LCT (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Propofol |
Inj 10 mg per ml, 100 ml vial; 10 vial pack |
$39.00 |
$39.90 |
Fresofol 1% MCT/LCT (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Risedronate sodium |
Tab 35 mg; 4 tablet blister pack |
$2.50 |
$3.00 |
Risedronate Sandoz (Sandoz) |
1 September 2025 |
1 February 2026 |
Sodium chloride |
Inj 0.9%, 5 ml ampoule; 20 plastic ampoule pack |
$4.00 |
$4.12 |
Fresenius Kabi (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Sodium chloride |
Inj 0.9%, 10 ml ampoule; 50 plastic ampoule pack |
$5.25 |
$7.50 |
Fresenius Kabi (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Sodium chloride |
Inj 0.9%, 20 ml ampoule; 20 plastic ampoule pack |
$5.00 |
$5.20 |
Fresenius Kabi (Fresenius Kabi) |
1 September 2025 |
1 February 2026 |
Sodium citrate with sodium lauryl sulphoacetate |
Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml; 50 Enema tube |
$35.89 |
$36.89 |
Micolette (AFT) |
1 September 2025 |
1 February 2026 |
Sodium cromoglicate |
Eye drops 2%; 10 ml dropper bottle |
$2.62 |
$2.91 |
Allerfix (Teva) |
1 October 2025 |
1 March 2026 |
Sodium hyaluronate [ Hyaluronic acid] |
Inj 10 mg per ml, 0.85 ml syringe; 1 glass ampoule injection |
$28.50 |
$28.50 |
Healon (Advanced Medical Optics) |
1 October 2025 |
1 March 2026 |
Sodium hyaluronate [ Hyaluronic acid] |
Inj 18 mg per ml, 0.85 ml syringe; 1 glass ampoule injection |
$50.00 |
$50.00 |
Healon GV Pro (Advanced Medical Optics) |
1 October 2025 |
1 March 2026 |
Sodium hyaluronate [ Hyaluronic acid] |
Inj 23 mg per ml, 0.6 ml syringe; 1 glass ampoule injection |
$60.00 |
$60.00 |
Healon 5 (Advanced Medical Optics) |
1 October 2025 |
1 March 2026 |
Sotalol |
Tab 80 mg; 500 tablet bottle pack |
$37.50 |
$40.00 |
Mylan (Viatris) |
1 September 2025 |
1 February 2026 |
Sotalol |
Tab 160 mg; 100 tablet bottle pack |
$14.00 |
$20.00 |
Mylan (Viatris) |
1 September 2025 |
1 February 2026 |
Tamsulosin hydrochloride |
Cap 400 mcg; 100 capsule blister pack |
$22.31 |
$28.56 |
Tamsulosin-Rex (Rex Medical) |
1 September 2025 |
1 February 2026 |
Tenoxicam |
Tab 20 mg; 100 tablet blister pack |
$18.50 |
$23.50 |
Tilcotil (Viatris) |
1 September 2025 |
1 February 2026 |
Tetrabenazine |
Tab 25 mg; 112 tablet bottle pack |
$106.59 |
$126.02 |
Motetis (Douglas) |
1 September 2025 |
1 February 2026 |
Tranexamic acid |
Tab 500 mg; 60 tablet blister pack |
$10.45 |
$9.93 |
Mercury Pharma (Boucher) |
1 December 2025 |
1 May 2026 |
Vinorelbine |
Cap 20 mg; 1 capsule blister pack |
$30.00 |
$32.10 |
Vinorelbine Te Arai (TeArai) |
1 September 2025 |
1 February 2026 |
Vinorelbine |
Cap 30 mg; 1 capsule blister pack |
$40.00 |
$42.80 |
Vinorelbine Te Arai (TeArai) |
1 September 2025 |
1 February 2026 |
Vinorelbine |
Cap 80 mg; 1 capsule blister pack |
$60.00 |
$80.00 |
Vinorelbine Te Arai (TeArai) |
1 September 2025 |
1 February 2026 |
Zoledronic acid |
Inj 5 mg per 100 ml, bag; 1 bag |
$22.53 |
$19.45 |
Zoledronic Acid Viatris |
1 September 2025 |
1 February 2026 |
1This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 4 clause 2.3(c)(ii) of the 2024/25 Invitation to Tender. |
4. Tenders awarded to currently listed pharmaceuticals where at least one other brand is listed.
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
Date of subsidy change |
Principal Supply date |
Brand (Supplier) affected by delisting |
---|---|---|---|---|---|---|---|
Celecoxib |
Cap 100 mg; 60 capsule blister pack |
$3.45 Celecoxib Pfizer (Aspen) |
$3.60 |
Celebrex (Aspen) |
1 September 2025 |
1 February 2026 |
Celecoxib Pfizer (Aspen) |
Nimodipine |
Inj 0.2 mg per ml, 50 ml vial; 5 solution for injection vial pack |
$337.50 |
$337.50 |
Nimotop (Boucher) |
1 September 2025 |
1 February 2026 |
Nimotop (Bayer) |
Nimodipine |
Tab 30 mg; 100 tablet blister pack |
$350.00 |
$350.00 |
Nimotop (Boucher) |
1 September 2025 |
1 February 2026 |
Nimotop (Bayer) |
Tender declines – Products where no tender is to be awarded for Principal Supply Status
Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the 2024/25 Invitation to Tender, dated 31 October 2024.
Chemical Name |
Line Item |
---|---|
Intra-uterine device (non-hormonal) |
IUD Short |
Intra-uterine device (non-hormonal) |
IUD Medium |
Intra-uterine device (non-hormonal) |
IUD Long |
Paracetamol with codeine |
Tab paracetamol 500 mg with codeine phosphate 15 mg |
Sodium hyaluronate [Hyaluronic acid] |
Inj 11-15 mg/ml syringe |
Voriconazole |
Powder for oral suspension 40 mg per ml |
Water for injection |
Purified for inj, 250 ml bag |
For products included in the 2022/23, 2023/24 and 2024/25 Invitation to Tender where no announcement has yet been made, a decision is still pending subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.